During chronic viral infections, CD8+ T cells lose much of their ability to proliferate, produce cytokines and kill. A new discovery shows how to restore their antiviral function.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Activation or exhaustion of CD8+ T cells in patients with COVID-19
Cellular & Molecular Immunology Open Access 19 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rehermann, B. & Nascimbeni, M. Nat. Rev. Immunol. 5, 215–229 (2005).
Barber, D.L. et al. Nature 439, 682–687 (2006).
Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. EMBO J. 11, 3887–3895 (1992).
Chen, L. Nat. Rev. Immunol. 4, 336–347 (2004).
Matloubian, M., Concepcion, R.J. & Ahmed, R. J. Virol. 68, 8056–8063 (1994).
Lichterfeld, M. et al. J. Exp. Med. 200, 701–712 (2004).
Brown, J.A. et al. J. Immunol. 170, 1257–1266 (2003).
Probst, H.C., McCoy, K., Okazaki, T., Honjo, T. & van den Broek, M. Nat. Immunol. 6, 280–286 (2005).
Pantaleo, G. & Koup, R.A. Nat. Med. 10, 806–810 (2004).
Leach, D.R., Krummel, M.F. & Allison, J.P. Science 271, 1734–1736 (1996).
Dittmer, U. et al. Immunity 20, 293–303 (2004).
Prokunina, L. et al. Nat. Genet. 32, 666–669 (2002).
Nishimura, H. et al. Science 291, 319–322 (2001).
Ansari, M.J. et al. J. Exp. Med. 198, 63–69 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shin, EC., Rehermann, B. Taking the brake off T cells in chronic viral infection. Nat Med 12, 276–277 (2006). https://doi.org/10.1038/nm0306-276
Issue Date:
DOI: https://doi.org/10.1038/nm0306-276
This article is cited by
-
Activation or exhaustion of CD8+ T cells in patients with COVID-19
Cellular & Molecular Immunology (2021)
-
PD-1/PD-L1 Blockade Can Enhance HIV-1 Gag-specific T Cell Immunity Elicited by Dendritic Cell-Directed Lentiviral Vaccines
Molecular Therapy (2012)